nkf-pharma
Nanjing
About nkf-pharma
Nanjing King-friend Biochemical Pharmaceutical is focused on research, production, and sales of raw material medicines of heparin sodium. It mainly produces a series of products including heparin sodium and low molecular heparin. Nanjing King-friend Biochemical Pharmaceutical was restructured and founded in March 2005. As of today, it owns two subsidiaries and two holding subsidiaries and its registered capital is 36 million. Its output of heparin sodium accounts for 20% of the world’s heparin sodium.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Funding stage: IPO
- Last round: Series Unknown (Apr 2011)
- Ticker: sse:603707
- Website: nkf-pharma.com
- Phone: 86 25 8699 0700
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/nkf-pharma-1760205 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.